Coya Therapeutics COYA
NASDAQ COYA
$3.94 -0.20 (-4.83%)
At close: Oct 23, 2026 · 4:00 PM EDT

Coya Therapeutics (COYA) Cash from Investing Activities (2022 - 2026)

Updated

Coya Therapeutics' Cash from Investing Activities was -$1,656 in Q2 2026.

Analysis

Coya Therapeutics (COYA) Cash from Investing Activities (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Coya Therapeutics' Cash from Investing Activities was -$1.54 million through Jun 30, 2026; for FY2025, it came in at -$1.16 million.

  • In earlier years, Cash from Investing Activities was -$25,000 in FY2024, -$543,186 in FY2023, -$525,000 in FY2022 and -$136,804 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -2.71 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -1.20 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -2.91 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -10.35 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.11 Bn
10 Coya Therapeutics 92.42 Mn -76.45 Mn - -1,656.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,656.00
Mar 31, 2026 -885,000.00
Dec 31, 2025 -648,606.00
Mar 31, 2024 -25,000.00
Dec 31, 2023 -193,186.00
Dec 31, 2022 -390,000.00
API Access

Coya Therapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=COYA&period=max&api_key=YOUR_API_KEY